FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
03/15/2025
Back to search
Official data from USPTO
DNADX
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
34
Latest update
04/03/2026
Trademark type
Word
Nice classes
1, 5
Filing date
02/06/2023
Registration date
09/17/2024
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
09/17/2024
Last transaction
04/03/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
16
Owner location
ES
Examiner
WOLD, BARBARA NIELSEN
Law office
M50
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
R. S. (pessoa física)
Representatives
Donna A. Tobin Royer Cooper Cohen Braunfeld LLP
Technical classification
Nice Classes
Class 1Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Diagnostic preparations for scientific purposesin the field of cancer; reagents for research purposesin the field of cancer; reagents for medical researchin the field of cancer; diagnostic reagents for scientific or research usein the field of cancer; reagents for scientific or research use in the field of cancer; diagnostic reagents for in vitro use in biochemistryclinical chemistry and microbiologyin the field of cancer
Class 5
Diagnostic preparations for medical purposesin the field of cancer; diagnostic reagents for medical usein the field of cancer; diagnostic biomarker reagents for medical purposesin the field of cancer; clinical medical reagentsin the field of cancer; medical diagnostic reagents for use in analysis of circulating tumor DNA extracted from blood samplesfor use in the field of cancer; medical diagnostic reagents for use in diagnostic testsin the field of cancer; biomarkers being copy number alterations and gene mutation for the diagnosisprognosis and treatment of cancer; medical diagnostic reagents and assays for the diagnosisprognosis and treatment of cancer; pharmaceutical preparations for the treatment of cancer; biological preparations for the treatment of cancer; biopharmaceuticals for the treatment of cancer; compoundschemotherapy drugsinmunotherapy agentstargeted drug therapies and hormonal therapies for treating cancer; pharmaceutical preparations for use in oncology; biological reagents for medical usein the field of cancer; diagnostic reagent kits comprised of medical diagnostic reagents and assays for testing body fluids for medical use in the field of cancer.
Publications
History of USPTO decisions and trademark events.
34 publications found
FICS
FINAL DISPOSITION NOTICE SENT TO IB
02/24/2025
FIMP
FINAL DISPOSITION PROCESSED
02/24/2025
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
12/17/2024
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
09/17/2024
R.PR
REGISTERED-PRINCIPAL REGISTER
09/17/2024
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
08/31/2024
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
08/14/2024
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
08/14/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
07/02/2024
PUBO
PUBLISHED FOR OPPOSITION
07/02/2024
GPNX
NOTIFICATION PROCESSED BY IB
07/01/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
06/12/2024
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
06/11/2024
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
06/11/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
05/28/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
05/07/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
05/07/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
05/07/2024
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
02/12/2024
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
02/12/2024
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
02/12/2024
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
02/12/2024
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
02/12/2024
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
02/12/2024
RFNP
REFUSAL PROCESSED BY IB
11/28/2023
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
11/07/2023
RFRR
REFUSAL PROCESSED BY MPU
11/07/2023
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
11/04/2023
CNRT
NON-FINAL ACTION WRITTEN
11/03/2023
DOCK
ASSIGNED TO EXAMINER
11/03/2023
MAFR
APPLICATION FILING RECEIPT MAILED
03/21/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
03/17/2023
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
03/16/2023
Continuous trademark protection
Get notified about every new filing that threatens DNADX or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.